Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




A Simple Finger Device Test Could Predict Future Heart Events

By HospiMedica International staff writers
Posted on 06 Apr 2009
A noninvasive sensory finger test is highly predictive of a major cardiac event (such as a heart attack or stroke) for people who are considered to be at low or moderate risk, according to a new study.

The EndoPAT noninvasive finger test device measures the health of endothelial cells, which line the blood vessels and regulate normal blood flow. More...
The device consists of digital recording equipment and two finger probes that look like large thimbles. For the test, which takes 15 minutes, probes are placed on each index finger and connected to a meter that measures blood flow. A standard blood pressure cuff is placed on one arm, and the arm without the cuff serves as the control. A reading of the fingers' blood flow rate begins, and then the blood pressure cuff on one arm is inflated for a few minutes and then deflated, allowing for three timed readings. The role of the inflated blood pressure cuff is to occlude and then release blood flow to assess reactive hyperemia (RH), the normal blood flow response that occurs when occlusion is released. A low RH signal, indicating a lower blood flow response, was found to be consistent with endothelial dysfunction and potentially impaired vascular health that may lead to or serve as a marker for future events. The EndoPAT finger test device is a product of Itamar Medical (Caesarea, Israel).

In a recent study conducted by researchers at the Mayo Clinic (Rochester, MN, USA) and Tufts-New England Medical Center (Boston, MA, USA) the device was used to test 270 patients between the ages of 42 and 66. These patients already knew that they had low-to-medium risk of experiencing a major heart event, based on their Framingham Risk Score, a commonly used risk predictor; 49% of these patients who went on to have a cardiac event had a low RH score, validating the test results for endothelium function. The study was presented at the American College of Cardiology annual scientific session, held during March 2009 in Orlando (FL, USA).

"The results of the study may help identify a discriminating tool beyond the Framingham Risk Score," said lead author of the study Amir Lerman, M.D., a cardiologist at Mayo Clinic. "And the results of these individual tests may help physicians change a patient's medications or recommend other therapies, so they don't have a heart attack or stroke later on."

Related Links:

Itamar Medical
Mayo Clinic
Tufts-New England Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.